3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hematologic Neoplasms
1
HIV Infections
1
Interventions
Cyclophosphamide
12
Vincristine
10
Doxorubicin
10
Etoposide
8
Rituximab
6
Prednisone
6
Cytarabine
6
Dexamethasone
5
Bleomycin
5
Zidovudine
4
Methotrexate
4
Leucovorin
4
Filgrastim
4
Peripheral Blood Stem Cell Transplantation
3
sargramostim
2
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Vinblastine
2
Polymerase Chain Reaction
2
Melphalan
2
Dacarbazine
2
Carmustine
2
Antiretroviral Therapy, Highly Active
2
Allopurinol
2
prednylidene
1
pembrolizumab
1
liposomal doxorubicin
1
ibrutinib
1
efavirenz
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HIV Infections
×
Nurse Clinicians
×
Lymphoid
×
Clear all
NCT00466258
2009-11-25
LINFOTARGAM
PETHEMA Foundation
Phase 4
Completed
50 enrolled